LPDL1

About TRIMT

TRIMT is a private, inventor-founded biotech company pioneering targeted radiopharmaceuticals for cancer theranostics. Its pipeline is centered on novel compounds targeting integrins like αvβ6 and αvβ8, as well as PD-L1, for both diagnostic imaging and radioligand therapy. The company leverages a strong scientific foundation, key academic collaborations, and an experienced leadership team to translate its discoveries from preclinical development into clinical trials.

Therapeutic Areas